The formation of the revamped Homeland Security Advisory Council (HSAC) under Trump's leadership may have implications for industries related to border security, law enforcement, and pharmaceuticals. However, the direct impact on the overall stock market is likely to be minimal, as the announcement is more focused on national security and policy rather than economic or financial matters. Historically, Trump's statements on immigration and border control have been met with mixed reactions from the market, with some sectors experiencing increased volatility. The mention of stopping the flow of fentanyl and other illegal drugs could potentially benefit pharmaceutical companies working on addiction treatment or drug interception technologies, but this effect is likely to be limited. Overall, the market sentiment remains neutral, as the announcement does not introduce significant new information that would substantially alter the current market trends or investor confidence.